Your browser doesn't support javascript.
loading
Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
Daley-Yates, Peter; Keppler, Brian; Baines, Amanda; Bardsley, George; Fingleton, James.
Afiliação
  • Daley-Yates P; Respiratory Clinical Development, GSK Research and Development, Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex, UB11 1BT, UK. Peter.T.Daley-Yates@gsk.com.
  • Keppler B; Metabolon Inc., 617 Davis Drive, Suite 100, Morrisville, NC, 27560, USA.
  • Baines A; Medicines Development Centre, GSK Research and Development, Stevenage, UK.
  • Bardsley G; Tauranga Hospital, 829 Cameron Road, Tauranga South, Tauranga, 3112, New Zealand.
  • Fingleton J; Medical Research Institute of New Zealand, Wellington, New Zealand.
Respir Res ; 23(1): 258, 2022 Sep 20.
Article em En | MEDLINE | ID: mdl-36127726
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Álcoois Benzílicos / Clorobenzenos / Androstadienos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Álcoois Benzílicos / Clorobenzenos / Androstadienos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article